Press release

Business Wire7 May 2026

Ukko Announces First Participant Dosed in Phase 1/2a Clinical Study Evaluating UKK-0018 for Peanut Allergy Treatment

Safety, tolerability, and preliminary efficacy data expected by early 2027 BOSTON–(BUSINESS WIRE)–#UKK0018–Ukko, Inc., a biotechnology company re-inventing immunotherapy for allergic…
Read More »
Press Release

Cision PR Newswire7 May 2026

Persistent Achieves Databricks Brickbuilder Specialization for Healthcare & Life Sciences, Expanding Production-Ready Data and AI Solutions For Regulated Environments

Enables HLS organizations to unify multimodal data, accelerate clinical and real-world evidence workflows, and operationalize governed AI at scale SANTA…
Read More »
Press Release

Cision PR Newswire7 May 2026

Celerium Announces Strategic Partnership with NDIA

FALLS CHURCH, Va., May 7, 2026 /PRNewswire/ — Celerium®, a cybersecurity company focused on defense contractor protection, today announced a…
Read More »
Press Release

Cision PR Newswire7 May 2026

SaaS’ next $100 billion opportunity could come from agentic AI – Bain & Co research

BOSTON, May 7, 2026 /PRNewswire/ — New research from Bain & Company released today shows a $100 billion US market…
Read More »
Cision PR Newswire7 May 2026

Accounting Software for Accountants Switching Clients to Digital Tools (2026): QuickBooks Recognised as a Leading UK MTD Solution by Consumer365

NEW YORK, May 7, 2026 /PRNewswire/ — As the UK begins the rollout of Making Tax Digital for Income Tax, new…
Read More »
Press Release

Cision PR Newswire7 May 2026

Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2026 Financial Results

NDA submitted for neladalkib in TKI pre-treated advanced ALK-positive NSCLC NDA for zidesamtinib in TKI pre-treated advanced ROS1-positive NSCLC under…
Read More »
Cision PR Newswire7 May 2026

BCE reports first quarter 2026 results

This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section…
Read More »
Press Release

Cision PR Newswire7 May 2026

Multi Investment accelerates its diversification strategy following a CHF 480 million capital raise

GENEVA, May 7, 2026 /PRNewswire/ — Following a significant capital raise of CHF 480 million, Multi Investment confirms its position as…
Read More »
Press Release

Cision PR Newswire7 May 2026

Automotive HUD Market worth $4.71 billion by 2033 | MarketsandMarkets™

DELRAY BEACH, Fla., May 7, 2026 /PRNewswire/ — According to MarketsandMarkets™, the automotive HUD market is projected to grow from USD 2.41…
Read More »
Press Release

Cision PR Newswire7 May 2026

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

SOLAIRIA-1 AND SOLAIRIA-2 Phase 3 clinical trials for GB-0895 (anti-TSLP) continue to advance Clinical trial sites activated for GB-4362 (MMAE…
Read More »

Previous page Next page